Dana Goldman, Ph.D. Leonard D. Schaeffer Chair and Director Schaeffer Center for Health Policy and Economics University of Southern California

Disclosures Financial Interests: Please provide information on financial interests that could be perceived to influence responsibilities and decision making process of the Access to Clinical Research Information Board (ATCRIB). This should include financial relationships with AbbVie and other pharmaceutical or biotechnology companies within the last three years. Check all that are applicable:

I currently work for a pharmaceutical company or have done so in the last three years. I work for a contract research and development company or have done so in the last three years. I provide expert advice (consulting) to a pharmaceutical X Abbott, AbbVie, Allergen, , Amylin, company or have done so in the last three years. AstraZeneca, Idec, Bristol-Myers, Squibb, Celgene, Eli Lilly, , Gilead, Janssen, J&J, Merck, Novartis, Orexo, Otsuka, , rEVO Biologics, Roche, Sanofi-Aventis, Shire, Sunoviaon, Takeda I participate in a strategic advisory role on an Advisory Board/Steering Committee that drives the strategic direction of a pharmaceutical company or have done so in the last three years. I earn an honorarium from a pharmaceutical company. I hold a patent (planned, pending or issued) relating to a pharmaceutical product. I am a principal investigator or have been in the last X three years. I am an investigator or have been in the last three years. My organization currently receives funding/a grant or X Dana Goldman is a partner at Precision has funding/a grant pending from a pharmaceutical Health Economics, which has research company. contracts with pharmaceutical companies Someone in my household (spouse/partner, minor children) works for a pharmaceutical company. I personally own shares (including options) in a pharmaceutical company. Someone in my household (spouse/partner, minor children) owns shares in a pharmaceutical company. I am involved in a lawsuit as an expert witness.

Other Real or Potential Conflicts of Interest Please provide any other (e.g., non-financial) real or potential conflicts of interest that could be perceived to influence the responsibilities and decision-making process of this independent panel. For example, potential biases based on pre-existing personal views, academic or commercial competition, personal relationships or institutional affiliations.

Not Applicable

Management of Conflicts of Interest Summarize how real or potential conflicts of interest related to the funding of the proposed research, other financial relationships, or other real or potential conflicts of interest will be managed (for example, through disclosure of interest statements when the research is presented or published).

Will disclose all relevant interests as necessary

Dana Goldman July 1, 2014